TalkMed Group's book value per share for the quarter that ended in Dec. 2024 was S$0.06.
During the past 12 months, TalkMed Group's average Book Value Per Share Growth Rate was -7.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 0.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of TalkMed Group was 58.70% per year. The lowest was -96.60% per year. And the median was 5.65% per year.
TalkMed Group's current price is S$0.44. Its book value per share for the quarter that ended in Dec. 2024 was S$0.06. Hence, today's PB Ratio of TalkMed Group is 6.98.
During the past 13 years, the highest P/B Ratio of TalkMed Group was 18.54. The lowest was 5.29. And the median was 7.14.
Warning Sign:
TalkMed Group Ltd stock PB Ratio (=6.98) is close to 5-year high of 7.3.
TalkMed Group Book Value per Share Historical Data
The historical data trend for TalkMed Group's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TalkMed Group's Book Value per Share
For the Medical Care Facilities subindustry, TalkMed Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TalkMed Group's PB Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where TalkMed Group's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
TalkMed Group (SGX:5G3) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
TalkMed Group Book Value per Share Related Terms
Thank you for viewing the detailed overview of TalkMed Group's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into two reportable operating segments, Oncology Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, China and Hong Kong, Australia, Vietnam and others of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:5G3 has been successfully added to your 